俞云松附属邵逸夫医院 | 医学院临床医学· 感染性疾病诊断· 细菌耐药机制研究及耐药菌感染治疗· 耐药细菌分子流行病学个人简介:俞云松，男，1965年5月生，主任医师、教授、博士研究生导师；现任浙江大学医学院附属邵逸夫医院副院长，感染科主任，浙江省细菌耐药监控中心副主任；2004年获教育部新世纪优秀人才支持计划资助，2007年获浙江省卫生厅首届高层出创新人才。1988毕业于浙江医科大学医学系毕业，获学士学位；1995.8获浙江医科大学传染病学博士学位，2002.12-2009.7任浙江大学医学院附属一院传染科主任医师、博士生导师，2009.8-至今任浙江大学医学院附属邵逸夫医院副院长、感染科主任、博士生导师。现任中华微生物与免疫学会临床微生物专业组副组长、中华传染病与寄生虫病学会青年委员、浙江省微生物与免疫学会主任委员、浙江省传染病与寄生虫病学会常务委员、浙江省预防医学会医院感染控制专业组委员、浙江省预防医学会微生态学专业组委员；《中华检验医学杂志》编委、《中国感染与化疗杂志》编委、《中国感染控制杂志》编委、《中国抗生素杂志》编委；J Antimicrob Chemother（IF 5.06）杂志审稿专家。1990年以来，一直从事细菌耐药机理、耐药细菌感染及治疗的研究，已发表论著50余篇，其中被SCI收录29篇。作为主要参加者获得2011年教育部科学技术进步奖一等奖1项、2007年国家科技进步二等奖1项。 近5年来主持国家自然科学基金4项，国家高科技发展计划（863计划）项目1项，国家基础研究发展计划（973计划）项目1项，教育部博士点基金1项，浙江省重点科技计划1项。*教育和训练背景1983.09－1988.08 原浙江医科大学医学系    本科生1990.09－1992.08 原浙江医科大学传染病学  硕士研究生1992.09 - 1995.12 原浙江医科大学传染病学  博士研究生 *工作经历1988.09－1993.08 浙江大学医学院附属第一医院传染科 住院医师1993.09－1997.12 浙江大学医学院附属第一医院传染科 主治医师1998.01－2002.12 浙江大学医学院附属第一医院传染科 副主任医师2003.01－2009.07 浙江大学医学院附属第一医院感染科 主任医师、教授2008.03－至今 传染病诊治国家重点实验室 教授2009.08－至今 浙江大学医学院附属邵逸夫医院感染科 主任医师、教授工作研究项目:*近五年作为负责人的研究项目1.   国家自然科学基金重点项目，鲍曼不动杆菌主要抗菌药物耐药机制研究，2013－2017；280万，主持人；2.   重大科技专项重点社会发展项目，重要感染性疾病预警技术的研究，2016-2019，110万，主持人；3.   国家自然科学基金面上项目，鲍曼不动杆菌基因组突变和移动元件在多重耐药形成中的作用2017-202080万，主持人；4.   国家科技部973前期项目，新超级细菌“广泛耐药鲍曼不动杆菌”毒力与耐药进化机制，2014-201674万，课题负责人；（已结题）5.   国家自然科学基金面上项目，中国产NDM-1超级细菌毒力及耐药传播分子机制研究，2012－2015；59万，主持人（已结题）；6.   卫生部卫生行业公益性基金重大项目，临床多重耐药菌医院感染防控研究及应用，2011－2013；249.6万，子课题负责人（已结题）；7.   国家自然科学基金面上项目，多重耐药鲍曼不动杆菌全基因组测序和“耐药岛”的比较基因组学分析，2010－2012；36万，主持人（已结题）；教学与课程:实用临床基础研究与成果:*近五年代表性论文 1.        Quan JJ Li X Chen Y Jiang Y Zhou ZH Zhang HC Sun L Ruan Z Feng Y Akova M Yu YS*. Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study. Lancet Infect Dis. 2017 Jan 27.  Epub ahead of print2.        Quan JJ Zhao DD Liu LL Chen Y Zhou JC Jiang Y Du XX Zhou ZH Murat Akova Yu YS*. High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China. J Antimicrob Chemother. 2017;72(1):273-280.3.        Pi BR Yu DL Hua XT Ruan Z Yu YS*. Genomic and transcriptome analysis of triclosan response of a multidrug-resistant Acinetobacter baumannii strainMDR-ZJ06. Arch Microbiol. 2017;199(2):223-230.4.        Mu XL Wang NF Li X Shi KR Zhou ZH Yu YS* Hua XT*. The Effect of Colistin Resistance-Associated Mutations on the Fitness of Acinetobacter baumannii. Front Microbiol. 2016 ;7:1715.5.        Shen P Yi ML Fu Ying Ruan Z Du XX Yu YS* Xie XY*. Detection of an Escherichia coli Sequence Type 167 Strain with Two Tandem Copies of blaNDM-1 in the Chromosome. J Clin Microbiol. 2016 Dec 28;55(1):199-205.6.        He F Xu J Wang JF Chen Q Hua XT Fu Y Yu YS*. Decreased Susceptibility to Tigecycline Mediated by a Mutation in mlaA in Escherichia coli Strains. Antimicrob Agents Chemother. 2016 ;60(12):7530-1.7.        Hua XT Sun LY Shi KR Yu YS*. Draft genome sequence of ST203 vanA Enterococcus faecium strain XH877 from China. J Glob Antimicrob Resist. 2016 ;7:24-25.8.        Fang L Chen Q Shi KR Li X Shi QC He F Zhou JC Yu YS* Hua XT*. Step-Wise Increase in Tigecycline Resistance in Klebsiella pneumoniae Associated with Mutations in ramR lon and rpsJ. Plos One. 2016 ;11(10):e0165019.9.        Li X Quan JJ Yang YX Ji JS Liu LL Fu Y Hua XT Chen Y Pi BR Jiang Y Yu YS*. Abrp a new gene confers reduced susceptibility to tetracycline glycylcine chloramphenicol and fosfomycin classes in Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis. 2016;35(8):1371-5.10.    Yang YX Wang JF Fu Y Ruan Z Yu YS*. Acinetobacter seifertii Isolated from China Genomic Sequence and Molecular Epidemiology Analyses. Medicine (Baltimore). 2016 ;95(9):e2937.11.    Jiang Y Wei ZQ Wang YF Hua XT Feng Y Yu YS*. Tracking a hospital outbreak of KPC-producing ST11 Klebsiella pneumoniae with whole genome sequencing. Clin Microbiol Infect. 2015. 21(11): 1001-7.12.    Jiang Y Shen P Wei ZQ Liu LL He F Shi KR Wang YF Wang HP Yu YS*. Dissemination of a clone carrying a fosA3-harbouring plasmid mediates high fosfomycin resistance rate of KPC-producing Klebsiella pneumoniae in China. Int J Antimicrob Agents. 2015. 45(1): 66-70.13.    Chen Y Yeh.AJ Cheung.GY Villaruz.AE Tan VY Joo HS Chatterjee SS Yu YS* Otto M*. Basis of virulence in a Panton-Valentine leukocidin-negative community-associated MRSA Strain. J Infect Dis. 2015. 211(3): 472-80.14.    Pi BR Yu DL Dai F Song X Zhu C Li H Yu YS*. A Genomics Based Discovery of Secondary Metabolite Biosynthetic Gene Clusters in Aspergillus ustus. PLoS One. 2015. 23;10(2): e0116089.15.    Li X Liu LL Ji JS Chen Q Hua XT Jiang Y Feng Y Yu YS*. Tigecycline resistance in Acinetobacter baumannii mediated by frameshift mutation in plsC encoding 1-acyl-sn-glycerol-3-phosphate acyltransferase. Eur J Clin Microbiol Infect Dis. 2015. 34(3): 625-31.16.    Qu TT Zhou JC Jiang Y Shi KR Li B Shen P Wei ZQ Yu YS*. Clinical and microbiological characteristics of Klebsiella pneumoniae liver abscess in East China. BMC Infect Dis. 2015. 27;15(1): 161.17.    He F Fu Y Chen Q Ruan Z Hua X Zhou H Yu YS*. Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae. PloS One.2015. 10(3): e0119064.18.    Liu LL Ji SJ Ruan Z Fu Y Fu YQ Wang YF Yu YS*. Dissemination of blaOXA-23 in Acinetobacter spp. in China: Main Roles of Conjugative Plasmid pAZJ221 and Transposon Tn2009. Antimicrob Agents Chemother. 2015. 59(4): 1998-2005.19.    Yang Q Fang LF Fu Y Du XX Shen YQ Yu YS*. Dissemination of NDM-1-Producing Enterobacteriaceae Mediated by the IncX3-Type Plasmid. PLoS One. 2015. 10(6): e0129454.20.    Ji SJ Lv FF Du XX Wei ZQ Fu Y Mu XL Jiang Y Yu YS*. Cefepime combined with amoxicillin/clavulanic acid: a new choice for the KPC-producing K. pneumoniae infection. Int J Infect Dis. 2015. 38: 108-114.21.    Yu DL Pi BR Chen Y Wang YF Ruan Z Otto M Yu YS*. Characterization of the staphylococcal cassette chromosome composite island of Staphylococcus haemolyticus SH32 a methicillin-resistant clinical isolate from China. PLoS One. 2014. 23;9(1): e87346.22.    Hua XT Chen Q Li X Feng Y Ruan Z Yu YS*. Complete Genome Sequence of Klebsiella pneumoniae Sequence Type 17 a Multidrug-Resistant Strain Isolated during Tigecycline Treatment. Genome Announc. 2014. 24;2(6). pii: e01337-14.23.    Fu YQ Jiang J Zhou H Jiang Y Fu Y Yu YS* Zhou J*. Characterization of a Novel Plasmid Type and Various Genetic Contexts of bla(OXA-58) in Acinetobacter spp. from Multiple Cities in China. PloS One. 2014. 6;9(1): e84680.24.    Wang JF Ruan Z Feng Y Fu Y Jiang Y Wang HP Yu YS*. Species distribution of clinical Acinetobacter isolates revealed by different identification techniques. PLoS One. 2014. 13;9(8): e104882.25.    Hua XT Chen Q Li X Yu YS*. Global transcriptional response of Acinetobacter baumannii to a subinhibitory concentration of tigecycline. Int J Antimicrob Agents. 2014. 44(4): 337-44.26.    Ji SJ Chen Y Ruan Z Fu Y Ji JS Fu YQ Wang HP Yu YS*. Prevalence of carbapenem-hydrolyzing class D beta-lactamase genes in Acinetobacter spp. isolates in China. Eur J Clin Microbiol Infect Dis. 2014. 33(6): 989-97.27.    Du XX Hua XT Qu TT Jiang Y Zhou ZH Yu YS*. Molecular characterization of Rifr mutations in Enterococcus faecalis and Enterococcus faecium. J Chemotherapy. 2014. 26(4): 217-21.28.    Yu DL Pi BR Yu MH Wang YF Ruan Z Feng Y Yu YS*. Diversity and evolution of oligopeptide permease systems in staphylococcal species. Genomics. 2014. 104(1): 8-13.29.    Qu TT Feng Y Jiang Y Zhu PQ Wei ZQ Chen Y Otto M Yu YS*. Whole Genome Analysis of a Community-Associated Methicillin-Resistant Staphylococcus aureus ST59 Isolate from a Case of Human Sepsis and Severe Pneumonia in China. PloS One. 2014. 9(2): e89235.30.    Chen Q Li X Zhou H Jiang Y Chen Y Hua XT Yu YS*. Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase. J Antimicrob Chemother. 2014. 69(1): 72-6.31.    Ji JS Du XX Chen Y Fu Y Wang HP Yu YS*. In vitro activity of sulbactam in combination with imipenem meropenem panipenem or cefoperazone against clinical isolates of Acinetobacter baumannii. Int J Antimicrob Agents. 2013 . 41(4): 400-1.32.     Yang XJ Chen Y Yang Q Qu TT Liu LL Wang HP Yu YS*. Emergence of cfr-harboring coagulase-negative Staphylococci among patients received linezolid therapy in two hospitals in China. J Med Microbiol. 2013. 62(Pt 6): 845-50.33.    Du XX Fu Y Yu YS*. Tigecycline treatment of infection caused by KPC-producing Escherichia coli in a pediatric patient. Ann Clin Microb Antimicrob. 2013. 13;12(1): 19. 34.    Du XX Wang JF Fu Y Zhao F Chen Y Wang HP Yu YS*. Genetic characteristics of blaNDM-1-positive plasmid in Citrobacter freundii isolate separated from a clinical infectious patient. J Med Microbiol. 2013. 62(Pt 9): 1332-7.    35.    Ruan Z Chen Y Jiang Y Zhou H Zhou ZH Fu Y Wang HP Wang YF Yu YS*. Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China. Int J Antimicrob Agents. 2013. 42(4): 322-8.36.    Ji JSWang J Zhou ZH Wang HP Jiang Y Yu YS*. Multilocus Sequence Typing Reveals Genetic Diversity of Carbapenem- or Ceftazidime-Nonsusceptible Pseudomonas aeruginosa in China. Antimicrob. Agents Chemother. 2013. 57(11): 5697-700.37.    Qu TT Yang Q Shen P Wei ZQ Yu YS*. Novel vancomycin-resistance transposon plasmid replicon types and virulence factors of vancomycin-resistant Enterococci in Zhejiang China. Microb Drug Resist. 2012. 18(2): 183-8.   38.    Zhou JC Zheng SW Yu YX Rouleau K Jiang WL Jin CW Zhou DY Pan KH Yu YS*. Trends in computed tomography utilization and association with hospital outcomes in a Chinese emergency department. PLoS One. 2012. 7(7):e40403.39.    Fu Y Du XX Ji JS Cheng Y Jiang Y Yu YS*. Epidemiological characteristics and genetic structure of blaNDM-1 in non-baumannii Acinetobacter spp. in China. J Antimicrob Chemother. 2012. 67(9): 2114-22.  40.    Hua XT Zhou H Jiang Y Feng Y Yu YS*. Genome Sequences of Two Multidrug-Resistant Acinetobacter baumannii Strains Isolated from a Patient before and after Treatment with Tigecycline. J Bacteriol.. 2012. 194(24): 6979-80.奖励荣誉:浙江省医药卫生科技创新一等奖中华医学科技二等奖浙江省科技进步一等奖浙江省科技厅浙江省科技进步一等奖浙江省科技厅 20011201浙江省科技进步二等奖浙江省科技厅 20001201